Search Results
Results found for "Montana Molecular"
- RAB-Symposium - Regulatory Autoantibodies Targeting GPCRs. September 15-16, 2022. Lübeck, Germany...
So far, numerous therapeutics targeting GPCRs have been developed, with a focus on small molecules and
- Drug Discovery Picks Up the Pace, Stays on Target
They include small molecules that conditionally modulate proteins in their functional state; three-dimensional
- Conservation of Allosteric Ligand Binding Sites in G-Protein Coupled Receptors
studied by protein mapping using the FTMap server, which determines the clustering of small organic probe molecules
- Accelerating GPCR Drug Discovery With Conformation-Stabilizing VHHs
approximately 850 GPCRs) has been successfully drugged, and obtaining highly potent and selective small molecules
- GPCR kinase phosphorylation of distal C-tail sites specifies βarrestin1-mediated signaling by...
phosphorylation sites are required for recruitment of the adaptor protein STAM1 (signal-transducing adaptor molecule
- Although the cannabinoid type-2 receptor (CB2) is highly expressed in the immune system, emerging...
The development of new CB2-related pharmacological and genetic tools, including the first small molecule
- Statin-induced increase in actin polymerization modulates GPCR dynamics and compartmentalization
parameters of serotonin1A receptors in normal cells are consistent with models describing the diffusion of molecules
- Maria’s Travel Blogs: ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025
This talk gave a general idea of what goes into designing small molecule drugs, using state-of-the-art
- Pharmacological targeting of cGAS/STING-YAP axis suppresses pathological angiogenesis and...
Pharmacological targeting of cGAS/STING-YAP signaling by both a small-molecule STING agonist, SR-717,
- AlphaFold’s Breakthrough in GPCR Research: Revolutionizing Discovery, Yet Awaiting Experimental Proof
this accuracy to synthetic compounds, limiting its utility in drug discovery involving novel drug-like molecules
- Engineered synaptic tools reveal localized cAMP signaling in synapse assembly
Here, we describe new tools, referred to as "SynTAMs" for synaptic targeting molecules, that enable localized
- Integration and Spatial Organization of Signaling by G Protein-Coupled Receptor Homo- and ...
essential in biology and understanding how cells integrate signals from a variety of information-coding molecules
- The Imprecision Problem: Why Your GPCR Drug Discovery Program Is Off-Track Before It Even Starts
Ambiguous Decision Gates: Molecules advance or stall based on vibes, not criteria.
- Adhesion GPCR Consortium Newsletter - May 2024
This was because, at that time, the neurexins, another family of adhesion molecules that also happened one of my colleagues to join this select group, which was getting together to talk about my favorite molecules
- Why “Displacement” Misleads You: Allosteric Binding Demystified
But in allosteric systems , adding a modulator doesn’t push another molecule off—it transforms the receptor
- Radioligands vs. Fluorescent Ligands: Binding Assays
One of the atoms in the original molecule is replaced by a radionuclide, which emits radiation.
- β2-Adrenergic Receptor Expression and Intracellular Signaling in B Cells Are Highly Dynamic during..
Adrenergic receptors on B cells and intracellular β2-ADR downstream molecules (G protein-coupled receptor
- Decoding β-Arrestins: from Structure to function
Tissue expression levels of β-Arrestins and their implications in cancer In addition to molecular interactions
- Phenylalanine 193 in Extracellular Loop 2 of the β 2-Adrenergic Receptor Coordinates β-Arrestin ...
Despite decades of research on the signaling consequences of molecule-receptor interactions, conformational
- How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs
Originally developed as ultra-bright lanthanide probes, the team realized they could tune these molecules
- How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights
This week’s Terry’s Corner exposes the unseen physiological “opponents” your molecule faces—and how
- Integrating Fluorescent Ligands into Flow Cytometry: Enhancing GPCR Analysis Beyond Traditional Antibody Staining
Fluorescent ligands based on small molecules bind to the functional sites of receptors in live cells,
- Your GPCR Program Decisions Depend on Good Data Interpretation
Ingo Hartung : State-of-the-art design of small molecule drugs, including PROTACs Dr.
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
peptide-1 receptor dimerization differentially regulates agonist signaling but does not affect small molecule
- Orthosteric vs. Allosteric Interactions: The Silent Decider of Safety and Success
This means you can design molecules that potentiate beneficial pathways without shutting down basal signaling
- Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right
Breakthroughs this week: 5-MeO-DMT: the "God Molecule"; Novo Nordisk looks to next generation of obesity
- Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling
operate on the principle of energy transfer between a fluorescent or luminescent donor and acceptor molecules
- Exendin-4 Attenuates Remodeling in the Remote Myocardium of Rats After an Acute Myocardial ...
Administration of Exendin-4 to MI rats reduced the infarct size and reversed the aforementioned signaling molecules
- Regulators of G-protein signaling: essential players in GPCR signaling
proteins has been implicated in a range of diseases, and understanding the mechanisms of these complex molecules
- Odorant receptors – a bit of smell for drug discovery
highly expressed by olfactory sensory neurons of the nose where they are activated by different odorant molecules











